Title: A concise enantioselective synthesis of (-)-ranirestat.
Journal: Organic letters 20100319
Title: Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review.
Journal: Journal of diabetes and its complications 20100101
Title: Inventing and understanding catalytic, enantioselective reactions.
Journal: Current opinion in drug discovery & development 20091101
Title: Ranirestat for the management of diabetic sensorimotor polyneuropathy.
Journal: Diabetes care 20090701
Title: Improvement of motor nerve conduction velocity in diabetic rats requires normalization of the polyol pathway metabolites flux.
Journal: Journal of pharmacological sciences 20090201
Title: An improved lanthanum catalyst system for asymmetric amination: toward a practical asymmetric synthesis of AS-3201 (Ranirestat).
Journal: Organic letters 20080703
Title: Long-term treatment with ranirestat (AS-3201), a potent aldose reductase inhibitor, suppresses diabetic neuropathy and cataract formation in rats.
Journal: Journal of pharmacological sciences 20080701
Title: Ranirestat (AS-3201), a potent aldose reductase inhibitor, reduces sorbitol levels and improves motor nerve conduction velocity in streptozotocin-diabetic rats.
Journal: Journal of pharmacological sciences 20080701
Title: Stability and hydrolysis kinetics of spirosuccinimide type inhibitors of aldose reductase in aqueous solution and retardation of their hydrolysis by the target enzyme.
Journal: Journal of pharmaceutical sciences 20080401
Title: Ranirestat as a therapeutic aldose reductase inhibitor for diabetic complications.
Journal: Expert opinion on investigational drugs 20080401
Title: Stereospecific recognition of a spirosuccinimide type aldose reductase inhibitor (AS-3201) by plasma proteins: a significant role of specific binding by serum albumin in the improved potency and stability.
Journal: Biochemical pharmacology 20060112
Title: Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy.
Journal: Diabetes care 20060101
Title: [Role of polyol pathway in pathogenesis of diabetic microangiopathy].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20050601
Title: [Progress on the drug therapy for diabetic microangiopathies: aldose reductase inhibitor].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20050601
Title: Aldose reductase inhibition by AS-3201 in sural nerve from patients with diabetic sensorimotor polyneuropathy.
Journal: Diabetes care 20041001
Title: Uridine diphosphate sugar-selective conjugation of an aldose reductase inhibitor (AS-3201) by UDP-glucuronosyltransferase 2B subfamily in human liver microsomes.
Journal: Biochemical pharmacology 20040401
Title: Stereospecific interaction of a novel spirosuccinimide type aldose reductase inhibitor, AS-3201, with aldose reductase.
Journal: Biochemistry 20010727
Title: Matsumoto T, et al. Improvement of motor nerve conduction velocity in diabetic rats requires normalization of the polyol pathway metabolites flux. J Pharmacol Sci. 2009 Feb;109(2):203-10.
Title: Toyoda F, et al. Effect of ranirestat, a new aldose reductase inhibitor, on diabetic retinopathy in SDT rats. J Diabetes Res. 2014;2014:672590.
